Glycans as Targets for Drug Delivery in Cancer
Innovative strategies have been proposed to increase drug delivery to the tumor site and avoid cytotoxicity, improving the therapeutic efficacy of well-established anti-cancer drugs. Alterations in normal glycosylation processes are frequently observed in cancer cells and the resulting cell surface...
Main Authors: | Francisca Diniz, Pedro Coelho, Henrique O. Duarte, Bruno Sarmento, Celso A. Reis, Joana Gomes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/4/911 |
Similar Items
-
In Planta Glycan Engineering and Functional Activities of IgE Antibodies
by: Laura Montero-Morales, et al.
Published: (2019-09-01) -
Adhesion of Helicobacter Species to the Human Gastric Mucosa: A Deep Look Into Glycans Role
by: Rita Matos, et al.
Published: (2021-05-01) -
Surface Engineering of HEK293 Cell-Derived Extracellular Vesicles for Improved Pharmacokinetic Profile and Targeted Delivery of IL-12 for the Treatment of Hepatocellular Carcinoma
by: Zhang J, et al.
Published: (2023-01-01) -
Expression Profiling and Glycan Engineering of IgG Subclass 1–4 in Nicotiana benthamiana
by: Somanath Kallolimath, et al.
Published: (2020-07-01) -
Multiple Roles of Glycans in Hematological Malignancies
by: Xingchen Pang, et al.
Published: (2018-09-01)